Literature DB >> 15194757

RBP-J (CSL) is essential for activation of the K14/vGPCR promoter of Kaposi's sarcoma-associated herpesvirus by the lytic switch protein RTA.

Yuying Liang1, Don Ganem.   

Abstract

The Kaposi's sarcoma-associated herpesvirus (KSHV) gene product virally encoded G protein-coupled receptor (vGPCR) is a homolog of cellular GPCRs and has been proposed to play important roles in KSHV-induced angiogenesis. The most abundant vGPCR-containing transcripts are K14/vGPCR bicistronic RNAs that are strongly induced during lytic reactivation. Here we show that the promoter governing this transcript is strongly responsive to activation by the viral lytic switch protein RTA. By deletion mapping and scanning mutation analyses, we have identified three putative RTA response elements (A, B, and C) in this promoter. However, none of these sites appear to directly bind RTA in electrophoretic mobility shift assays (EMSA). Site C corresponds to a canonical binding site for RBP-J, a sequence-specific transcriptional repressor that is normally the target of Notch signaling. RBP-J can bind RTA and recruit it to its cognate recognition site; when this happens, the activation function of RTA can relieve RBP-J-mediated repression and upregulate expression of the targeted gene. EMSA studies reveal that both sites A and C can bind to RBP-J; sequence inspection reveals that site A is a novel functional variant of known RBP-J recognition sites. (Site B corresponds to an as-yet-unknown host DNA-binding protein.) The importance of sites A and C in vivo is underscored by the observation that K14/vGPCR promoter function is dramatically inhibited in cells genetically deficient in RBP-J. The regulation of K14/vGPCR transcripts by RBP-J raises the possibility that other modulators of Notch signaling might be able to induce expression of this RNA outside the context of lytic KSHV replication.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194757      PMCID: PMC421686          DOI: 10.1128/JVI.78.13.6818-6826.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  70 in total

Review 1.  Deciphering the role of Notch signaling in lymphopoiesis.

Authors:  David J Izon; Jennifer A Punt; Warren S Pear
Journal:  Curr Opin Immunol       Date:  2002-04       Impact factor: 7.486

2.  Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture.

Authors:  M C Gershengorn; E Geras-Raaka; A Varma; I Clark-Lewis
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

Review 3.  Modulators of Notch signaling.

Authors:  V M Panin; K D Irvine
Journal:  Semin Cell Dev Biol       Date:  1998-12       Impact factor: 7.727

4.  Identification of a cellular protein that interacts and synergizes with the RTA (ORF50) protein of Kaposi's sarcoma-associated herpesvirus in transcriptional activation.

Authors:  S Wang; S Liu; M H Wu; Y Geng; C Wood
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus.

Authors:  Chuang-Jiun Chiou; Lynn J Poole; Peter S Kim; Dolores M Ciufo; Jennifer S Cannon; Colette M ap Rhys; Donald J Alcendor; Jian-Chao Zong; Richard F Ambinder; Gary S Hayward
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

6.  Open reading frame 50 protein of Kaposi's sarcoma-associated herpesvirus directly activates the viral PAN and K12 genes by binding to related response elements.

Authors:  Pey-Jium Chang; Duane Shedd; Lyn Gradoville; Myung-Sam Cho; Lee-Wen Chen; Jimmy Chang; George Miller
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

7.  Kaposi's Sarcoma-associated herpesvirus open reading frame 50 stimulates the transcriptional activity of STAT3.

Authors:  Yousang Gwack; Seungmin Hwang; Chunghun Lim; Young Suk Won; Chul Ho Lee; Joonho Choe
Journal:  J Biol Chem       Date:  2001-12-11       Impact factor: 5.157

8.  Kaposi's sarcoma-associated herpesvirus OX2 glycoprotein activates myeloid-lineage cells to induce inflammatory cytokine production.

Authors:  Young-Hwa Chung; Robert E Means; Joong-Kook Choi; Bok-Soo Lee; Jae U Jung
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

9.  A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus.

Authors:  R Sun; S F Lin; L Gradoville; Y Yuan; F Zhu; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

10.  Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein.

Authors:  D M Lukac; R Renne; J R Kirshner; D Ganem
Journal:  Virology       Date:  1998-12-20       Impact factor: 3.616

View more
  42 in total

1.  Notch1 regulates the expression of the multidrug resistance gene ABCC1/MRP1 in cultured cancer cells.

Authors:  Sungpil Cho; Meiling Lu; Xiaolong He; Pui-Lai Rachel Ee; Uppoor Bhat; Erasmus Schneider; Lucio Miele; William T Beck
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

2.  Multiple defects, including premature apoptosis, prevent Kaposi's sarcoma-associated herpesvirus replication in murine cells.

Authors:  Kathryn Austgen; Scott A Oakes; Don Ganem
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

3.  Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4/K10) is a novel interaction partner of CSL/CBF1, the major downstream effector of Notch signaling.

Authors:  Katharina Heinzelmann; Barbara A Scholz; Agnes Nowak; Even Fossum; Elisabeth Kremmer; Juergen Haas; Ronald Frank; Bettina Kempkes
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

4.  KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2.

Authors:  Mark Cannon; Ethel Cesarman; Chris Boshoff
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

5.  Kaposi's Sarcoma-associated herpesvirus lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway.

Authors:  Kyla Driscoll Carroll; Wei Bu; Diana Palmeri; Sophia Spadavecchia; Stephen J Lynch; Salvatore A E Marras; Sanjay Tyagi; David M Lukac
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

6.  The transcriptional repressor K-RBP modulates RTA-mediated transactivation and lytic replication of Kaposi's sarcoma-associated herpesvirus.

Authors:  Zhilong Yang; Charles Wood
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

7.  Promoter- and cell-specific transcriptional transactivation by the Kaposi's sarcoma-associated herpesvirus ORF57/Mta protein.

Authors:  Diana Palmeri; Sophia Spadavecchia; Kyla Driscoll Carroll; David M Lukac
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

8.  Genome-wide identification of binding sites for Kaposi's sarcoma-associated herpesvirus lytic switch protein, RTA.

Authors:  Jiguo Chen; Fengchun Ye; Jianping Xie; Kurt Kuhne; Shou-Jiang Gao
Journal:  Virology       Date:  2009-02-23       Impact factor: 3.616

9.  The phosphatase Shp2 is required for signaling by the Kaposi's sarcoma-associated herpesvirus viral GPCR in primary endothelial cells.

Authors:  Thomas Bakken; Meilan He; Mark L Cannon
Journal:  Virology       Date:  2009-12-09       Impact factor: 3.616

10.  Wide-scale use of Notch signaling factor CSL/RBP-Jkappa in RTA-mediated activation of Kaposi's sarcoma-associated herpesvirus lytic genes.

Authors:  Linda M Persson; Angus C Wilson
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.